Showing results (1571-1580 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|March 30, 2022
Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United StatesScott J Keating, Tao Gu, Monika P Jun, et al.Transplantation and Cellular Therapy|March 21, 2022
UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including MinoritiesMaude Dumont-Lagacé, Albert Feghaly, Marie-Christine Meunier, et al.Transplantation and Cellular Therapy|January 2, 2026
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence from Machine Learning and Regression ModelsAshish Narayan Masurekar, Kelly M Burkett, Arya Rahgozar, et al.Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.Transplantation and Cellular Therapy|April 13, 2026
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemiaYasuyuki Arai, Marie Ohbiki, Mio Kurata, et al.Transplantation and Cellular Therapy|April 20, 2026
Incidence, Risk Factors and Outcomes of Sinusoidal Obstruction Syndrome in Patients undergoing Allogeneic Hematopoietic Cell Transplantation with PTCy-based ProphylaxisLaura Creus-Vilalta, María Suárez-Lledó, Julia Martínez-Sánchez, et al.Transplantation and Cellular Therapy|June 24, 2023
Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host DiseaseRebecca Gonzalez, Eric Gaskill, Maya Padilla, et al.Transplantation and Cellular Therapy|June 4, 2023
Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor AssociationRachel Pawson, Chloe Anthias, Meghann Cody, et al.Transplantation and Cellular Therapy|June 10, 2023
Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell TransplantationAlma Wegener, Niels Smedegaard Andersen, Lone Smidstrup Friis, et al.Pageof 183